Urology · Toms River, NJ
NPI
1952357543
Since 2006
Specialty
Urology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
67 Route 37 West, Riverwood 2 Suite 1
Toms River, NJ, 08755
Phone (732) 914-1300
Groups this clinician bills Medicare through
Medicare paid, 2024
$467K
8,649 services
Medicare patients, 2024
1,766
Average age 77
Drug cost, 2024
$1.1M
6,357 prescriptions
Company payments, 2025
$532
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter C Howard was code 81003 (clinical chemistry), 2,177 times for 1,462 patients. In total Peter C Howard billed 8,649 services in 70 codes, and Medicare paid $467K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 2,177 | 1,462 | $2.19 | $4,774 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,671 | 19 | $2.21 | $3,687 |
| 99214 Office E&M - Established | Office | 1,467 | 1,030 | $99.38 | $146K |
| 99213 Office E&M - Established | Office | 979 | 788 | $68.72 | $67K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 418 | 45 | $140.09 | $59K |
| 99232 Hospital E&M - Subsequent | Facility | 244 | 106 | $64.67 | $16K |
| 99204 Office E&M - New | Office | 198 | 198 | $131.43 | $26K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 169 | 165 | $85.14 | $14K |
| 74420 Standard X-ray | Facility | 168 | 94 | $19.88 | $3,340 |
| 51741 Test - Miscellaneous | Office | 158 | 155 | $11.17 | $1,765 |
| 52000 Cystourethroscopy | Office | 101 | 92 | $196.40 | $20K |
| 99222 Hospital E&M - Initial | Facility | 93 | 92 | $107.06 | $9,956 |
| 96402 Chemotherapy Administration | Office | 76 | 45 | $30.42 | $2,312 |
| 51720 Chemotherapy Administration | Office | 62 | 22 | $74.55 | $4,622 |
| 55700 Other Organ Systems | Facility | 54 | 54 | $95.78 | $5,172 |
By year: 2022 $526K for 9,120 services; 2023 $510K for 9,992 services; 2024 $467K for 8,649 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 2,177 | 1,462 | $2.19 | $4,774 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter C Howard prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,768 prescriptions and refills. In total Peter C Howard wrote 6,357 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,768 | 4,958 | 531 | $35K |
| Myrbetriq Mirabegron | 766 | 1,816 | 236 | $788K |
| Finasteride Generic | 575 | 1,613 | 160 | $8,974 |
| Solifenacin Succinate Generic | 570 | 1,567 | 225 | $31K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 330 | 414 | 226 | $1,484 |
| Ciprofloxacin Hcl Generic | 322 | 332 | 228 | $1,271 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 273 | 733 | 84 | $10K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 132 | 134 | 97 | $1,601 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 113 | 113 | 89 | $612 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 109 | 259 | 35 | $4,527 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 109 | 325 | 33 | $3,946 |
| Levofloxacin Generic | 101 | 101 | 97 | $283 |
| Gemtesa Vibegron | 99 | 225 | 42 | $106K |
| Silodosin Generic | 92 | 269 | 32 | $12K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 89 | 89 | 59 | $478 |
Brand drugs: - claims; generic drugs: 5,386 claims; opioid claims: 121.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter C Howard $532 ($532 in general payments such as food, travel and fees) from 15 companies. The largest payer was Sumitomo Pharma America, Inc. with $160.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.